Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Aug;12(4):203–207. doi: 10.1080/09629350310001599639

Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.

Alexander L Pukhalsky 1, Galina V Shmarina 1, Maria S Bliacher 1, Irina M Fedorova 1, Anna P Toptygina 1, Julia J Fisenko 1, Vladimir A Alioshkin 1
PMCID: PMC1781617  PMID: 14514470

Abstract

BACKGROUND AND AIM: Immunization with live virus vaccines may cause an immunosuppression with lymphopaenia, impaired cytokine production and defective lymphocyte response to mitogenes. These abnormalities were described in subjects vaccinated against measles. This study was performed to analyse the host immune response related to immunosuppression in subjects vaccinated with live attenuated rubella vaccine. METHODS: Eighteen schoolgirls, aged 11-13 years, were vaccinated with live attenuated rubella vaccine Rudivax. Before immunization, and 7 and 30 days after, peripheral blood was collected. Cellular fractions were subjected to flow cytometric analysis, and the lymphocyte response to phytohaemagglutinin was investigated. Plasma samples were analysed for cytokines (interleukin (IL)-4, IL-10, tumour necrosis factor-alpha, and interferon-gamma) by enzyme-linked immunosorbent assay techniques. RESULTS: On day 7 after vaccination, the number of each lymphocyte subset was decreased; however, only for CD3 and CD4 lymphocytes has a significant reduction been shown. On the contrary, tumour necrosis factor-alpha and IL-10 levels markedly increased and amounted to its maximum on day 30. Simultaneously, a significant reduction in plasma interferon-gamma and a profound decrease of the lymphocyte response to phytohaemagglutinin were shown. The changes were accompanied with marked elevation of plasma IL-4. CONCLUSIONS: Our data indicate that the vaccination with live attenuated rubella vaccine results in moderate but sustained immune disturbance. The signs of immunosuppression, including defective lymphocyte response to mitogene and impaired cytokine production, may persist for at least 1 month after vaccination.

Full Text

The Full Text of this article is available as a PDF (95.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaby P., Leeuwenburg J. Gender and the pattern of transmission of measles infection. A reanalysis of data from the Machakos area, Kenya. Ann Trop Paediatr. 1991;11(4):397–402. doi: 10.1080/02724936.1991.11747537. [DOI] [PubMed] [Google Scholar]
  2. Akaboshi I., Nagayoshi I., Omura M., Iwaki K. Elevated serum levels of interleukin-10 in children with acute rubella infection. Scand J Infect Dis. 2001;33(6):462–465. doi: 10.1080/00365540152029945. [DOI] [PubMed] [Google Scholar]
  3. Arsenijevic D., Girardier L., Seydoux J., Pechere J. C., Garcia I., Lucas R., Chang H. R., Dulloo A. G. Metabolic-cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection. Am J Physiol. 1998 Mar;274(3 Pt 1):E439–E445. doi: 10.1152/ajpendo.1998.274.3.E439. [DOI] [PubMed] [Google Scholar]
  4. Banatvala J. E., Best J. M., O'Shea S., Dudgeon J. A. Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis. 1985 Mar-Apr;7 (Suppl 1):S86–S90. doi: 10.1093/clinids/7.supplement_1.s86. [DOI] [PubMed] [Google Scholar]
  5. Best J. M. Rubella vaccines: past, present and future. Epidemiol Infect. 1991 Aug;107(1):17–30. doi: 10.1017/s0950268800048640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cusi M. G., Rossolini G. M., Valensin P. E., Cellesi C., Zanchi A. Serological evidence of reinfection among vaccinees during rubella outbreak. Lancet. 1990 Oct 27;336(8722):1071–1071. doi: 10.1016/0140-6736(90)92545-s. [DOI] [PubMed] [Google Scholar]
  7. Hussey G. D., Klein M. Routine high-dose vitamin A therapy for children hospitalized with measles. J Trop Pediatr. 1993 Dec;39(6):342–345. doi: 10.1093/tropej/39.6.342. [DOI] [PubMed] [Google Scholar]
  8. Miller E., Cradock-Watson J. E., Pollock T. M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982 Oct 9;2(8302):781–784. doi: 10.1016/s0140-6736(82)92677-0. [DOI] [PubMed] [Google Scholar]
  9. Okada H., Kobune F., Sato T. A., Kohama T., Takeuchi Y., Abe T., Takayama N., Tsuchiya T., Tashiro M. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol. 2000;145(5):905–920. doi: 10.1007/s007050050683. [DOI] [PubMed] [Google Scholar]
  10. Okada H., Sato T. A., Katayama A., Higuchi K., Shichijo K., Tsuchiya T., Takayama N., Takeuchi Y., Abe T., Okabe N. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch Virol. 2001;146(5):859–874. doi: 10.1007/s007050170121. [DOI] [PubMed] [Google Scholar]
  11. Reef Susan E., Frey Teryl K., Theall Katherine, Abernathy Emily, Burnett Cindy L., Icenogle Joseph, McCauley Mary Mason, Wharton Melinda. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA. 2002 Jan 23;287(4):464–472. doi: 10.1001/jama.287.4.464. [DOI] [PubMed] [Google Scholar]
  12. Rosenberg Y. J., Anderson A. O., Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol Today. 1998 Jan;19(1):10–17. doi: 10.1016/s0167-5699(97)01183-3. [DOI] [PubMed] [Google Scholar]
  13. Rosenberg Y. J., Cafaro A., Brennan T., Greenhouse J. G., Villinger F., Ansari A. A., Brown C., McKinnon K., Bellah S., Yalley-Ogunro J. Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections. Int Immunol. 1997 May;9(5):703–712. doi: 10.1093/intimm/9.5.703. [DOI] [PubMed] [Google Scholar]
  14. Shohat T., Green M. S., Nakar O., Ballin A., Duvdevani P., Cohen A., Shohat M. Gender differences in the reactogenicity of measles-mumps-rubella vaccine. Isr Med Assoc J. 2000 Mar;2(3):192–195. [PubMed] [Google Scholar]
  15. Smedman L., Joki A., da Silva A. P., Troye-Blomberg M., Aronsson B., Perlmann P. Immunosuppression after measles vaccination. Acta Paediatr. 1994 Feb;83(2):164–168. doi: 10.1111/j.1651-2227.1994.tb13043.x. [DOI] [PubMed] [Google Scholar]
  16. Vinante F., Krampera M., Morosato L., Rigo A., Romagnani S., Pizzolo G. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection. Haematologica. 1999 Aug;84(8):683–689. [PubMed] [Google Scholar]
  17. Ward B. J., Griffin D. E. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol. 1993 May;67(2):171–177. doi: 10.1006/clin.1993.1061. [DOI] [PubMed] [Google Scholar]
  18. Woiciechowsky C., Schöning B., Lanksch W. R., Volk H. D., Döcke W. D. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med (Berl) 1999 Nov;77(11):769–780. doi: 10.1007/s001099900051. [DOI] [PubMed] [Google Scholar]
  19. van der Poll T., Marchant A., Buurman W. A., Berman L., Keogh C. V., Lazarus D. D., Nguyen L., Goldman M., Moldawer L. L., Lowry S. F. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995 Dec 1;155(11):5397–5401. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES